NCT07384949

Brief Summary

This is a retrospective study including patients diagnosed with cutaneous squamous cell carcinoma between 2016 and 2025. Demographic, clinical, histopathological, and dermoscopic data were obtained from hospital records. Dermoscopic images taken with the FotoFinder dermoscope were independently evaluated by two dermatologists in a blinded manner. In addition, images were labeled using computer software and analyzed to measure the proportion of specific dermoscopic structures within the total lesion area. These quantitative data were used to examine the relationship between dermoscopic features and histopathological findings.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
238

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Feb 2026Jun 2026

First Submitted

Initial submission to the registry

January 27, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 3, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

January 27, 2026

Last Update Submit

January 27, 2026

Conditions

Keywords

dermoscopyDermoscopic featuresHistopathology correlationTumor invasion depthSkin cancer imagingComputer-assisted image analysisSquamous cell carcinoma

Outcome Measures

Primary Outcomes (1)

  • Correlation between dermoscopic features and tumor invasion depth

    The association between predefined dermoscopic features and histopathological tumor invasion depth will be evaluated using quantitative and qualitative dermoscopic assessments.

    Retrospective analysis of records from 2016 to 2025

Study Arms (1)

Cutaneous Squamous Cell Carcinoma Patients

This cohort includes patients diagnosed with cutaneous squamous cell carcinoma between 2016 and 2025 who underwent total excision and had available clinical, dermoscopic, and histopathological data in hospital records. No additional interventions were performed as part of the study.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients aged 18 to 100 years who were diagnosed with cutaneous squamous cell carcinoma and treated with total surgical excision between 2016 and 2025. Only cases with complete clinical, dermoscopic, and histopathological records, including documented tumor differentiation and invasion depth, were included. No additional diagnostic or therapeutic procedures were performed as part of the study.

You may qualify if:

  • Histopathologically confirmed cutaneous squamous cell carcinoma
  • Lesions that underwent total surgical excision
  • Histopathology reports including both tumor differentiation grade and invasion depth
  • Availability of dermoscopic images obtained prior to excision
  • Dermoscopic images of sufficient quality for evaluation and image analysis -

You may not qualify if:

  • Lesions that received any prior treatment, including radiotherapy, chemotherapy, cryotherapy, or other destructive or topical treatments before excision
  • Incomplete clinical, dermoscopic, or histopathological data
  • Poor-quality dermoscopic images not suitable for reliable evaluation or segmentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences, Istanbul Training and Research Hospital, Department of Dermatology

Istanbul, FATİH, 34098, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Carcinoma, Squamous Cell

Condition Hierarchy (Ancestors)

CarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsNeoplasms, Squamous Cell

Central Study Contacts

AYSE ESRA KOKU AKSU, Principal Investigator

CONTACT

SELMA NUR ŞAHİN, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dermatology Resident, MD

Study Record Dates

First Submitted

January 27, 2026

First Posted

February 3, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

February 3, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to patient confidentiality, institutional data protection policies, and the retrospective nature of the study. All analyses will be reported in aggregate form only.

Locations